Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.36 HKD
Change Today -0.14 / -9.33%
Volume 2.3M
401 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

wanjia group holdings ltd (401) Snapshot

Open
$1.40
Previous Close
$1.50
Day High
$1.48
Day Low
$1.30
52 Week High
06/16/15 - $2.38
52 Week Low
12/8/14 - $0.39
Market Cap
881.8M
Average Volume 10 Days
2.8M
EPS TTM
$-1.19
Shares Outstanding
648.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WANJIA GROUP HOLDINGS LTD (401)

Related News

No related news articles were found.

wanjia group holdings ltd (401) Related Businessweek News

No Related Businessweek News Found

wanjia group holdings ltd (401) Details

Wanjia Group Holdings Limited, an investment holding company, wholesales and distributes pharmaceutical products in the People’s Republic of China. It operates through two divisions, Pharmaceutical Wholesale and Distribution Business; and Pharmaceutical Retail Chain Business. The company sells its pharmaceutical products to public hospitals and healthcare institutions; distributor customers; and end customers, such as companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in the Fujian, Guangdong, Hunan, Hubei, Jiangxi, Aunhui, and Zhejiang provinces. Its retail pharmacies offer prescription medicines, over-the-counter medicines, healthcare food products, traditional Chinese medicines, medical supplies, and medical devices. As of March 31, 2015, the company had 119 retail pharmacies in Fujian Province under the Huihao Sihai brand name. The company was founded in 2004 and is headquartered in Hong Kong, Hong Kong. Wanjia Group Holdings Limited is a subsidiary of Greatly Wealth Global Group Limited.

Founded in 2004

wanjia group holdings ltd (401) Top Compensated Officers

Executive Director
Total Annual Compensation: $28.0K
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

wanjia group holdings ltd (401) Key Developments

Wanjia Group Holdings Limited Reports Audited Consolidated Earnings Results for the Full Year Ended March 31, 2015

Wanjia Group Holdings Limited reported audited consolidated earnings results for the full year ended March 31, 2015. For the year, the company reported loss from operations was HKD 756.511 million against profit of HKD 80.196 million a year ago. Loss before taxation was HKD 765.330 against profit of HKD 74.181 million a year ago. Diluted loss per share was 119.21 HK cents against 7.54 HK cents diluted earnings per share a year ago. Looking back at 2014/15, the Group's revenue experienced a decrease. The Group recorded revenue of approximately HKD 1,567.687 million against approximately HKD 2,096.455 million for the year ended 31 March 2014, accounting for a decrease of approximately 25.22% over last year. The Group recorded a loss attributable to owners of the company of approximately HKD 772.949 million during the year ended 31 March 2015 against profit of approximately HKD 48.920 million in 2014. The net loss was mainly attributable to the impairment loss on the goodwill of approximately HKD 785.169 million.

Wanjia Group Holdings Limited to Report Fiscal Year 2015 Results on Jun 29, 2015

Wanjia Group Holdings Limited announced that they will report fiscal year 2015 results on Jun 29, 2015

Wanjia Group Holdings Limited, Board Meeting, Jun 29, 2015

Wanjia Group Holdings Limited, Board Meeting, Jun 29, 2015., at 14:30 China Standard Time. Agenda: To consider and approve the audited annual results of the company and its subsidiaries for the year ended 31 March 2015 and approve the release of the announcement of the Annual Results; to consider the payment of a final dividend, if any; to consider the closure of the Register of Members, if necessary; to consider the time and venue of the forthcoming annual general meeting of the members of the company; and to transact any other business.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
401:HK $1.36 HKD -0.14

401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Nepstar Chain Drugstore Ltd $2.20 USD -0.03
Huadong Medicine Co Ltd CNY71.48 CNY 0.00
Jointown Pharmaceutical Group Co Ltd CNY19.58 CNY +0.88
Nanjing Pharmaceutical Co Ltd CNY13.04 CNY -1.45
Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd CNY78.24 CNY 0.00
View Industry Companies
 

Industry Analysis

401

Industry Average

Valuation 401 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 3.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANJIA GROUP HOLDINGS LTD, please visit www.wanjia-gp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.